Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

The therapeutic sc"enario of metastatic renal cell cancer (mRCC) has noticeably increased, ranging from the most studied molecular target therapies to those most recently introduced, up to immune checkpoint inhibitors (ICIs). The most recent clinical trials with an ICI-based combination of mole...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Roberto, Michela, Botticelli, Andrea, Panebianco, Martina, Aschelter, Anna Maria, Gelibter, Alain, Ciccarese, Chiara, Minelli, Mauro, Nuti, Marianna, Santini, Daniele, Laghi, Andrea, Tomao, Silverio, Marchetti, Paolo
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100507/
https://ncbi.nlm.nih.gov/pubmed/33968762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.657639
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares